(Q47687463)
Statements
The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis (English)
Navikas V
Matusevicius D
Söderström M
Pirskanen R
Fredrikson S